Ocular myasthenia gravis: response to long-term immunosuppressive treatment. - Wikidata - awgldk - TriplyDB

Ocular myasthenia gravis: response to long-term immunosuppressive treatment.

Ocular myasthenia gravis: response to long-term immunosuppressive treatment.

http://www.wikidata.org/entity/Q36902041

about

Medical and surgical treatment for ocular myasthenia Corticosteroids for myasthenia gravis Medical and surgical treatment for ocular myasthenia Medical and surgical treatment for ocular myasthenia Ocular motor dysfunction and ptosis in ocular myasthenia gravis: effects of treatment Clinical features, pathogenesis, and treatment of myasthenia gravis: a supplement to the Guidelines of the German Neurological Society Quality of life in purely ocular myasthenia in Japan.Juvenile myasthenia gravis: a paediatric perspective Perioperative management in myasthenia gravis: republication of a systematic review and a proposal by the guideline committee of the Japanese Association for Chest Surgery 2014.Ocular myasthenia gravis: a review.Paradigm shift in surgical approaches to thymectomy.Comparison of clinical manifestations between patients with ocular myasthenia gravis and generalized myasthenia gravis.Mycophenolate mofetil for myasthenia gravis: a clear and present controversy Ophthaproblem. Ocular myasthenia gravis Myasthenia gravis: a clinical-immunological update.Safety of prednisone for ocular myasthenia gravis.EFNS/ENS Guidelines for the treatment of ocular myasthenia.Glucocorticoids in myasthenia gravis - if, when, how, and how much?Myasthenia gravis: recent advances in immunopathology and therapy.Frontalis sling procedure for ocular myasthenia gravis.The effect of early prednisolone treatment on the generalization rate in ocular myasthenia gravis.Ocular presentation of myasthenia gravis: A natural history cohort.Low conversion rate of ocular to generalized myasthenia gravis in Singapore.Efficacy of prednisone for the treatment of ocular myasthenia (EPITOME): A randomized, controlled trial.Ocular myasthenia gravis: controversies and updates.

P2860

Q24202289-ECF5615A-DF97-474E-8323-6D73AD5E842F Q24244116-5E7C6302-EBC7-428A-BC1A-E5249DEC96BA Q24245255-E3E2B15D-5F2C-4811-AFD1-B6C904300335 Q24246392-9C0EC695-9F8C-4821-9089-9673E3E25B8C Q24670367-3BFD0B13-AF16-46DB-A7FD-CC4BE69EAF04 Q26765172-C426F896-FE0E-4462-844A-859958F7B013 Q33869796-3E79F930-4152-4937-A979-D813BA211032 Q34029492-D800EFCD-B8FF-461A-838B-76F108EE78DA Q34043022-F4156E6D-DCF4-4C63-9921-D4A33A46DA2C Q34450858-E8F43FB6-5E43-4F45-AA3A-578436FC1AEE Q34572505-8C20BC08-56C2-4B17-A7E9-64BAF649B147 Q34575021-5CFEFE05-A282-4E2D-A959-AB1D67EC2804 Q34606062-B4E07843-DDFF-4F7A-AEA9-3ABCBE88629A Q36405607-FCCDE388-8A9A-4482-BA85-A98A316CCE2C Q36783864-90FAF4A8-B900-4ABF-A607-EEF0A7B43CE9 Q37063766-59ACFE86-ABF3-4217-8312-E4D7C2144B3F Q38182650-A0315D85-0A47-43EF-9884-31BDEE537602 Q38234725-3505D54D-5BA9-430D-93F3-B1E69A2C30D3 Q38969032-D54EF38A-D24B-4E5E-8C01-5879AECE833D Q41785399-7B63D62A-D64B-4F88-89F0-32FA5B5C1D95 Q44046461-A68B961F-3CD5-4090-BE06-B85823A8BC12 Q48020624-66AE8115-5FAB-45E0-A7DA-5DFDC7089DDD Q49582626-D5B91654-0EFC-4349-A0E8-7A1CE5E4F28E Q50954321-BBB8BADE-EDE2-4C61-828E-33BACB3F0759 Q54394549-E5B50E9B-1CC7-4C20-9E12-C7B615529D1A

P2860

Ocular myasthenia gravis: response to long-term immunosuppressive treatment.

http://www.wikidata.org/entity/Q36902041

description

1997 nî lūn-bûn

@nan

1997年の論文

@ja

1997年論文

@yue

1997年論文

@zh-hant

1997年論文

@zh-hk

1997年論文

@zh-mo

1997年論文

@zh-tw

1997年论文

@wuu

1997年论文

@zh

1997年论文

@zh-cn

name

Ocular myasthenia gravis: response to long-term immunosuppressive treatment.

@en

type

label

Ocular myasthenia gravis: response to long-term immunosuppressive treatment.

@en

prefLabel

Ocular myasthenia gravis: response to long-term immunosuppressive treatment.

@en

P1433

Q36902041-8FC9D378-3365-4B26-A021-F5F2E88804DD

P1476

Q36902041-83B5B6FC-FEAC-47A0-88AC-1AA32C9F734D

P2093

Q36902041-2F5BA53A-B0B2-4289-8B64-34A75DA9D888

Q36902041-364E4A11-211C-4406-B133-CD2266C8C148

Q36902041-73C0103D-4E03-4E68-B3C1-6FAF744CF7BC

Q36902041-94E0E0CB-4050-4495-88F5-4490E7D67C77

Q36902041-A7B5BE17-0F1F-4598-843A-96FEA97CD91B

Q36902041-C72EECE2-EBF5-4E37-9A6E-D775E4C9754C

Q36902041-D95EAC17-A614-460B-B15C-DDFB9DE33495

P2860

Q36902041-042A51B4-60C9-4E4E-949E-B8AC9EBF6736

Q36902041-21F911E0-98A9-45AF-9CCB-CC6AF3AD4EB3

Q36902041-2A4719B7-D7F6-45A2-837F-F9470F0BCF3A

Q36902041-3E78824B-7DE8-4FD7-8046-6726D2ED23EA

Q36902041-5EBDE727-8C99-42E9-9D9F-3ED057476311

Q36902041-6A97ACAB-F968-42C8-AE67-CF32BDAF96FC

Q36902041-73E82D08-8B72-4B0D-94B8-F3B030CC409B

Q36902041-7472F064-A84E-415B-81CE-9E33094AF6C9

Q36902041-8299C8A8-52D6-43E7-B8E6-458541F86640

Q36902041-844A2D1A-E082-4A31-A552-8B28CA725064

P304

Q36902041-7AE4F55F-E26E-43CA-B7C0-AD227224A339

P31

Q36902041-ECAE9503-262E-451F-B830-5FC0C5D4E015

P356

Q36902041-917753DD-1FD6-43C6-BD4A-1E06926C3935

P407

Q36902041-9C1CA9C0-8EF3-4578-A993-60E16EC79806

P433

Q36902041-A44DCEE3-3066-413A-9319-DED166E05CD2

P478

Q36902041-291964CA-828E-4A0B-9135-73E966C3CB75

P577

Q36902041-C2F04C98-996C-4FAD-A5DF-AEBB8B8B559A

P5875

Q36902041-F85CD52D-213D-4A2F-B626-07DAAB26A4D8

P698

Q36902041-A6E0AE74-3D97-4629-BAE7-0C22312E940B

P921

Q36902041-83F58A83-FE8B-4EDE-841C-838F5FCFBA6B

P932

Q36902041-4F854329-A1E6-46E2-A521-A35321E44022

P356

P1433

Journal of Neurology, Neurosurgery and Psychiatry

P1476

Ocular myasthenia gravis: response to long-term immunosuppressive treatment.

@en

P2093

Dichgans J

http://www.w3.org/2001/XMLSchema#string

Herzau V

http://www.w3.org/2001/XMLSchema#string

Melms A

http://www.w3.org/2001/XMLSchema#string

Schepelmann K

http://www.w3.org/2001/XMLSchema#string

Sigg B

http://www.w3.org/2001/XMLSchema#string

Sommer N

http://www.w3.org/2001/XMLSchema#string

Weller M

http://www.w3.org/2001/XMLSchema#string

P2860

Long-term corticosteroid treatment of myasthenia gravis.

Thymectomy in myasthenia with pure ocular symptoms.

Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: results in 153 validated cases and 2967 diagnostic assays.

The natural course of myasthenia gravis: a long term follow up study.

Thymus in myasthenia gravis. Isolation of T-lymphocyte lines specific for the nicotinic acetylcholine receptor from thymuses of myasthenic patients.

Controversies about the treatment of myasthenia gravis.

Epidemiology of myasthenia gravis in Denmark. A longitudinal and comprehensive population survey.

Determination of acetylcholine receptor antibody in myasthenia gravis: clinical usefulness and pathogenetic implications.

Remission of myasthenia gravis following plasma-exchange.

The course of myasthenia gravis and therapies affecting outcome.

P304

156-162

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/JNNP.62.2.156

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

62

http://www.w3.org/2001/XMLSchema#string

P577

1997-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

14162148

http://www.w3.org/2001/XMLSchema#string

P698

9048716

http://www.w3.org/2001/XMLSchema#string

P921

myasthenia gravis

P932

486727

http://www.w3.org/2001/XMLSchema#string